Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Forbes John F. and Sestak Ivana and Howell Anthony and Bonanni Bernardo and Bundred Nigel and Levy Christelle and Minkwitz Gunter von and Eiermann Wolfgang and Neven Patrick and Stierer Michael and Holcombe Chris and Coleman Robert E. and Jones Louise and Ellis Ian and Cuzick Jack and Kahán Zsuzsanna: Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
LANCET, 387 (10021). pp. 866-873. ISSN 0140-6736 (2016)

[thumbnail of 1_s2.0_S0140673615011290_main_u.pdf]
Preview
Text
1_s2.0_S0140673615011290_main_u.pdf - Published Version

Download (409kB) | Preview
Item Type: Article
Journal or Publication Title: LANCET
Date: 2016
Volume: 387
Number: 10021
Page Range: pp. 866-873
ISSN: 0140-6736
Publisher: The Lancet Publishing Group
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3257984
DOI azonosító: https://doi.org/10.1016/S0140-6736(15)01129-0
Date Deposited: 2017. Aug. 30. 10:58
Last Modified: 2019. Nov. 29. 15:27
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11864
Web of Science® Times Cited: 102 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year